Randomized, Open Label, 2-way Crossover, Single Dose Bioequivalence Study of Paroxetine IR Tablets Manufactured in GSKT and Mississauga Sites in Healthy Chinese Participants Under Fasting and Fed Conditions
Phase of Trial: Phase I
Latest Information Update: 19 Sep 2018
At a glance
- Drugs Paroxetine (Primary)
- Indications Depressive disorders; Generalised anxiety disorder; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Post-traumatic stress disorders; Premenstrual dysphoric disorder; Social phobia
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 13 Aug 2018 Status changed from active, no longer recruiting to completed.
- 13 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 05 Jun 2018 Status changed from not yet recruiting to recruiting.